• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊切除术和淋巴结清扫术在 T2 期胆囊癌患者中的作用。

Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer.

出版信息

World J Surg. 2013 Nov;37(11):2635-40. doi: 10.1007/s00268-013-2187-2.

DOI:10.1007/s00268-013-2187-2
PMID:23959341
Abstract

BACKGROUND

Incidental findings of gallbladder cancer (GBCA) have dramatically increased as an initial presentation of the disease because of the expansion of laparoscopic cholecystectomy. However, the optimal management of T2 GBCA remains at issue.

METHODS

We compared our 10-year experience with the consensus surgical strategy for T2 GBCA. Between January 2000 and December 2009, 70 patients at Severance Hospital, Yonsei University Health System, Seoul, Korea, underwent surgical treatment for GBCA stage T2. The medical records of 70 patients with T2 GBCA were retrospectively reviewed.

RESULTS

Radical cholecystectomy was performed on only 32 (45.8 %) patients. In patients with T2 GBCA and positive lymph nodes (LN), the overall survival rate between cholecystectomy with LN dissection and radical cholecystectomy did not show a significant difference. Twenty patients experienced recurrence during the follow-up period. Among the 11 patients who underwent cholecystectomy with liver resection, only 2 (18.2 %) patients had an intrahepatic recurrence. Of the 9 patients who underwent cholecystectomy without liver resection, 3 (33.3 %) patients had an intrahepatic recurrence. However, recurrences at the gallbladder bed occurred only in one and two patients, respectively, and were not significantly different between the two groups.

CONCLUSIONS

There was a large gap between clinical practice and treatment guidelines. Though relatively few patients enrolled in this study experienced recurrence, cholecystectomy and LN dissection without liver resection showed similar survival and recurrence patterns compared with those of radical cholecystectomy. To improve consistency between clinical practice and consensus guidelines, the role of limited resection for T2 lesions needs further evaluation.

摘要

背景

由于腹腔镜胆囊切除术的广泛开展,胆囊癌(GBCA)的偶然发现作为该病的初始表现显著增加。然而,T2 GBCA 的最佳治疗方法仍存在争议。

方法

我们比较了我们 10 年的经验与 T2 GBCA 的共识手术策略。在 2000 年 1 月至 2009 年 12 月期间,韩国首尔延世大学健康系统塞弗伦斯医院对 70 例 GBCA 分期 T2 的患者进行了手术治疗。回顾性分析了 70 例 T2 GBCA 患者的病历。

结果

仅对 32 例(45.8%)患者进行了根治性胆囊切除术。在 T2 GBCA 合并阳性淋巴结(LN)的患者中,胆囊切除术加 LN 清扫术与根治性胆囊切除术之间的总生存率无显著差异。20 例患者在随访期间复发。在接受胆囊切除术加肝切除术的 11 例患者中,仅 2 例(18.2%)患者出现肝内复发。在 9 例未行肝切除术的患者中,3 例(33.3%)患者出现肝内复发。然而,胆囊床复发仅分别发生在 1 例和 2 例患者中,两组之间无显著差异。

结论

临床实践与治疗指南之间存在较大差距。尽管本研究中纳入的患者复发相对较少,但胆囊切除术加 LN 清扫术而不进行肝切除术与根治性胆囊切除术具有相似的生存和复发模式。为了使临床实践与共识指南之间更加一致,需要进一步评估 T2 病变的有限切除术的作用。

相似文献

1
Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer.胆囊切除术和淋巴结清扫术在 T2 期胆囊癌患者中的作用。
World J Surg. 2013 Nov;37(11):2635-40. doi: 10.1007/s00268-013-2187-2.
2
Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.对于T2期胆囊癌患者,肝侧肿瘤是否比腹膜侧肿瘤需要更广泛的切除?一项回顾性多中心研究的结果
Surgery. 2017 Sep;162(3):515-524. doi: 10.1016/j.surg.2017.05.004. Epub 2017 Jun 16.
3
Evaluation of Surgical Procedures for T2 Gallbladder Cancer in Terms of Recurrence and Prognosis.T2期胆囊癌手术方式的复发与预后评估
Kurume Med J. 2017 Apr 13;63(1.2):15-22. doi: 10.2739/kurumemedj.MS65005. Epub 2017 Mar 22.
4
Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding.腹腔镜胆囊切除术中偶然发现的胆囊癌:处理意外发现。
World J Gastroenterol. 2012 Aug 14;18(30):4019-27. doi: 10.3748/wjg.v18.i30.4019.
5
Optimal assessment of lymph node status in gallbladder cancer.胆囊癌淋巴结状态的最佳评估
Eur J Surg Oncol. 2016 Feb;42(2):205-10. doi: 10.1016/j.ejso.2015.10.013. Epub 2015 Nov 14.
6
Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer.手术方法和肿瘤位置对T2期胆囊癌患者根治性切除术后生存及复发模式的影响
Gut Liver. 2016 Jan;10(1):140-6. doi: 10.5009/gnl15080.
7
Radical resection improves survival for patients with pT2 gallbladder carcinoma.根治性切除术可提高pT2期胆囊癌患者的生存率。
Am Surg. 2001 Nov;67(11):1041-7.
8
Oncologic Outcomes of Extended Lymphadenectomy without Liver Resection for T1/T2 Gallbladder Cancer.T1/T2 期胆囊癌行扩大淋巴结清扫术而不进行肝脏切除术的肿瘤学结果。
Yonsei Med J. 2019 Dec;60(12):1138-1145. doi: 10.3349/ymj.2019.60.12.1138.
9
Surgical treatment of incidental gallbladder cancer discovered during or following laparoscopic cholecystectomy.腹腔镜胆囊切除术期间或术后发现的意外胆囊癌的手术治疗。
World J Surg. 2015 Mar;39(3):746-52. doi: 10.1007/s00268-014-2864-9.
10
Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations?T2期胆囊癌的管理:实践模式是否与国家建议一致?
Am J Surg. 2007 Dec;194(6):820-5; discussion 825-6. doi: 10.1016/j.amjsurg.2007.08.032.

引用本文的文献

1
A prognostic model and novel risk classification system for radical gallbladder cancer surgery: A population-based study and external validation.根治性胆囊癌手术的预后模型和新型风险分类系统:一项基于人群的研究及外部验证
Heliyon. 2024 Aug 2;10(15):e35551. doi: 10.1016/j.heliyon.2024.e35551. eCollection 2024 Aug 15.
2
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review.可切除胆管癌围手术期治疗的现状与未来展望:多学科综述
Cancers (Basel). 2021 Apr 1;13(7):1647. doi: 10.3390/cancers13071647.
3
T2 gallbladder cancer shows substantial survival variation between continents and this is not due to histopathologic criteria or pathologic sampling differences.

本文引用的文献

1
National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis.15 年以上手术治疗胆囊腺癌的管理和生存的国家趋势:基于人群的分析。
J Gastrointest Surg. 2010 Oct;14(10):1578-91. doi: 10.1007/s11605-010-1335-3. Epub 2010 Sep 8.
2
Rational therapeutic strategy for T2 gallbladder carcinoma based on tumor spread.基于肿瘤扩散的 T2 期胆囊癌的合理治疗策略。
World J Gastroenterol. 2010 Jul 28;16(28):3567-72. doi: 10.3748/wjg.v16.i28.3567.
3
Laparoscopic approach for suspected early-stage gallbladder carcinoma.
T2 期胆囊癌在各大洲之间存在显著的生存差异,这并非归因于组织病理学标准或病理取样差异。
Virchows Arch. 2021 May;478(5):875-884. doi: 10.1007/s00428-020-02968-5. Epub 2021 Jan 7.
4
A predictive nomogram for lymph node metastasis of incidental gallbladder cancer: a SEER population-based study.基于 SEER 数据库的偶然胆囊癌淋巴结转移预测列线图:一项基于人群的研究。
BMC Cancer. 2020 Aug 31;20(1):828. doi: 10.1186/s12885-020-07341-y.
5
Oncologic safety of laparoscopic radical cholecystectomy in pT2 gallbladder cancer: A propensity score matching analysis compared to open approach.pT2期胆囊癌腹腔镜根治性胆囊切除术的肿瘤学安全性:与开放手术对比的倾向评分匹配分析
Medicine (Baltimore). 2020 May;99(20):e20039. doi: 10.1097/MD.0000000000020039.
6
Clinicopathological Differences in T2 Gallbladder Cancer According to Tumor Location.根据肿瘤位置的不同,T2 期胆囊癌的临床病理差异。
Cancer Control. 2020 Jan-Dec;27(1):1073274820915514. doi: 10.1177/1073274820915514.
7
Oncologic Outcomes of Extended Lymphadenectomy without Liver Resection for T1/T2 Gallbladder Cancer.T1/T2 期胆囊癌行扩大淋巴结清扫术而不进行肝脏切除术的肿瘤学结果。
Yonsei Med J. 2019 Dec;60(12):1138-1145. doi: 10.3349/ymj.2019.60.12.1138.
8
Laparoscopic radical cholecystectomy with common bile duct resection for T2 gallbladder cancer.腹腔镜下根治性胆囊切除术联合胆总管切除术治疗T2期胆囊癌
Ann Hepatobiliary Pancreat Surg. 2019 Feb;23(1):69-73. doi: 10.14701/ahbps.2019.23.1.69. Epub 2019 Feb 28.
9
Resection of Hepatic Lesions Perfused by the Cholecystic Vein Using Indocyanine Green Navigation in Patients with cT2 Gallbladder Cancer.使用吲哚菁绿导航对cT2期胆囊癌患者经胆囊静脉灌注的肝脏病变进行切除术
World J Surg. 2019 Feb;43(2):608-614. doi: 10.1007/s00268-018-4810-8.
10
Surgical Strategy for T2 Gallbladder Cancer: Nationwide Multicenter Survey in Korea.韩国全国多中心调查:T2 期胆囊癌的手术策略。
J Korean Med Sci. 2018 May 30;33(28):e186. doi: 10.3346/jkms.2018.33.e186. eCollection 2018 Jul 9.
针对疑似早期胆囊癌的腹腔镜手术方法。
Arch Surg. 2010 Feb;145(2):128-33. doi: 10.1001/archsurg.2009.261.
4
Evolving treatment strategies for gallbladder cancer.胆囊癌不断发展的治疗策略。
Ann Surg Oncol. 2009 Aug;16(8):2101-15. doi: 10.1245/s10434-009-0538-x. Epub 2009 Jun 3.
5
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.美国国立综合癌症网络(NCCN)肿瘤学临床实践指南:肝胆癌
J Natl Compr Canc Netw. 2009 Apr;7(4):350-91. doi: 10.6004/jnccn.2009.0027.
6
A critical analysis of the surgical management of early-stage gallbladder cancer in the United States.美国早期胆囊癌手术治疗的批判性分析
J Gastrointest Surg. 2009 Apr;13(4):722-7. doi: 10.1007/s11605-008-0772-8. Epub 2008 Dec 13.
7
Surgery for gallbladder cancer: a population-based analysis.胆囊癌手术:一项基于人群的分析。
J Am Coll Surg. 2008 Sep;207(3):371-82. doi: 10.1016/j.jamcollsurg.2008.02.031. Epub 2008 May 12.
8
Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations?T2期胆囊癌的管理:实践模式是否与国家建议一致?
Am J Surg. 2007 Dec;194(6):820-5; discussion 825-6. doi: 10.1016/j.amjsurg.2007.08.032.
9
Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection.偶然发现的胆囊癌中残余病灶的检出率:对再次手术的影响
J Gastrointest Surg. 2007 Nov;11(11):1478-86; discussion 1486-7. doi: 10.1007/s11605-007-0309-6. Epub 2007 Sep 11.
10
Does "clinical" R0 have validity in the choice of simple cholecystectomy for gallbladder carcinoma?“临床”R0切除在胆囊癌单纯胆囊切除术的选择中是否有效?
J Gastrointest Surg. 2007 Oct;11(10):1309-16. doi: 10.1007/s11605-007-0225-9. Epub 2007 Aug 8.